Literature DB >> 9291857

The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument.

Z de Jong1, D van der Heijde, S P McKenna, D Whalley.   

Abstract

The present study was designed to test the psychometric properties of the RAQoL, a rheumatoid arthritis (RA)-specific quality of life (QoL) instrument. All stages of the development were conducted simultaneously in The Netherlands and the UK. The content of the draft measure was derived from qualitative interviews with RA patients in both countries. The final version of the RAQoL has 30 items with a 'yes'/'no' response format and takes approximately 6 min to complete. Both language versions have high internal consistency and test-retest reliability (> 0.9), and good sensitivity to discriminate between groups with various disease activity and severity. Given the excellent psychometric properties of the new instrument, it will prove to be a valuable tool for assessing quality of life in clinical trials and for monitoring patients in routine clinical practice.

Entities:  

Mesh:

Year:  1997        PMID: 9291857     DOI: 10.1093/rheumatology/36.8.878

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  59 in total

1.  Functional disability and quality of life in patients with ankylosing spondylitis.

Authors:  Stephen P McKenna; Lynda Doward
Journal:  Rheumatol Int       Date:  2003-10-24       Impact factor: 2.631

2.  Occurrences and sources of Differential Item Functioning (DIF) in patient-reported outcome measures: Description of DIF methods, and review of measures of depression, quality of life and general health.

Authors:  Jeanne A Teresi; Mildred Ramirez; Jin-Shei Lai; Stephanie Silver
Journal:  Psychol Sci Q       Date:  2008

3.  Patients' perceptions of health related quality of life in rheumatoid arthritis and chronic low back pain.

Authors:  Montserrat Núñez; Alex Sanchez; Esther Nuñez; Teresa Casals; Cayetano Alegre; José Muñoz-Gomez
Journal:  Qual Life Res       Date:  2006-02       Impact factor: 4.147

4.  The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension.

Authors:  S P McKenna; N Doughty; D M Meads; L C Doward; J Pepke-Zaba
Journal:  Qual Life Res       Date:  2006-02       Impact factor: 4.147

5.  Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis.

Authors:  L C Doward; A Spoorenberg; S A Cook; D Whalley; P S Helliwell; L J Kay; S P McKenna; A Tennant; D van der Heijde; M A Chamberlain
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

6.  The international development of the RGHQoL: a quality of life measure for recurrent genital herpes.

Authors:  L C Doward; S P McKenna; T Kohlmann; M Niero; D Patrick; B Spencer; H Thorsen
Journal:  Qual Life Res       Date:  1998-02       Impact factor: 4.147

7.  Laser acupuncture versus reflexology therapy in elderly with rheumatoid arthritis.

Authors:  Afnan Sedky Adly; Aya Sedky Adly; Mahmoud Sedky Adly; Zahra M H Serry
Journal:  Lasers Med Sci       Date:  2017-04-27       Impact factor: 3.161

Review 8.  Measurement properties of rheumatoid arthritis-specific quality-of-life questionnaires: systematic review of the literature.

Authors:  Jiyeon Lee; Soo Hyun Kim; Seung Hei Moon; Eun-Hyun Lee
Journal:  Qual Life Res       Date:  2014-05-21       Impact factor: 4.147

9.  Quality of life of patients with rheumatoid arthritis in Argentina: reliability, validity, and sensitivity to change of a Spanish version of the Rheumatoid Arthritis Quality of Life questionnaire.

Authors:  Christian A Waimann; Fernando M Dal Pra; Maria F Marengo; Emilce E Schneeberger; Susana Gagliardi; Jose A Maldonado Cocco; Mónica Sanchez; A Garone; Rafael E Chaparro del Moral; Oscar L Rillo; Mariana Salcedo; Javier E Rosa; F Ceballos; Enrique R Soriano; Gustavo Citera
Journal:  Clin Rheumatol       Date:  2012-04-04       Impact factor: 2.980

Review 10.  Using ultrasonography to facilitate best practice in diagnosis and management of RA.

Authors:  Andrew K Brown
Journal:  Nat Rev Rheumatol       Date:  2009-11-10       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.